Page last updated: 2024-09-02

bretazenil and Substance Withdrawal Syndrome

bretazenil has been researched along with Substance Withdrawal Syndrome in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ator, NA; Griffiths, RR; Kaminski, BJ; Weerts, EM1
Hönack, D; Löscher, W; Rundfeldt, C; Wlaź, P1
Bronson, ME1
Reddy, DS; Rogawski, MA1
Gibert-Rahola, J; Maldonado, R; Micó, JA; Valverde, O1
Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Pieri, L; Schoch, P1
Bonetti, EP; Burkard, WP; Cumin, R; Haefely, WE; Martin, JR; Pieri, L; Schaffner, R1

Other Studies

7 other study(ies) available for bretazenil and Substance Withdrawal Syndrome

ArticleYear
Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Animals; Behavior, Animal; Benzodiazepinones; Dose-Response Relationship, Drug; Eating; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Infusions, Parenteral; Male; Papio; Psychomotor Performance; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam

2005
Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:2

    Topics: Animals; Anticonvulsants; Benzodiazepinones; Carbolines; Diazepam; Disease Models, Animal; Drug Tolerance; Male; Mice; Receptors, GABA-A; Seizures; Substance Withdrawal Syndrome

1995
Chlordiazepoxide, but not bretazenil, produces acute dependence, as evidenced by disruptions in schedule-controlled behavior.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 48, Issue:2

    Topics: Animals; Benzodiazepinones; Chlordiazepoxide; Conditioning, Operant; Flumazenil; Male; Rats; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders

1994
Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.
    Epilepsia, 2001, Volume: 42, Issue:3

    Topics: Allosteric Regulation; Animals; Anticonvulsants; Benzodiazepinones; Desoxycorticosterone; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Female; Menstrual Cycle; Pentylenetetrazole; Phenobarbital; Pregnanolone; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Receptors, GABA; Steroids; Substance Withdrawal Syndrome; Valproic Acid

2001
Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice.
    Drug and alcohol dependence, 1992, Volume: 30, Issue:3

    Topics: Animals; Azides; Behavior, Animal; Benzodiazepines; Benzodiazepinones; Flumazenil; Flunitrazepam; Male; Mice; Morphine; Receptors, GABA-A; Substance Withdrawal Syndrome

1992
Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028.
    European journal of pharmacology, 1990, Nov-06, Volume: 190, Issue:1-2

    Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Drug Implants; Mice; Mice, Inbred DBA; Receptors, GABA-A; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam

1990
Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
    Pharmacopsychiatry, 1988, Volume: 21, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepinones; Cats; Conflict, Psychological; Cyclic GMP; Diazepam; Dogs; Flunitrazepam; Mice; Rats; Receptors, GABA-A; Saimiri; Substance Withdrawal Syndrome

1988